Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ola Samuelsson

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Clinical Pharmacokinetics|July 9, 2003
Influence of severe renal impairment on the pharmacokinetics and pharmacodynamics of oral ximelagatran and subcutaneous melagatranUlf G Eriksson, Susanne Johansson, Per-Ola Attman, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 28, 2015
Measured and not estimated glomerular filtration rate should be used to assess renal function in heart transplant recipientsOscar Kolsrud, Sven-Erik Ricksten, Erik Holmberg, et al.
Lakartidningen|August 28, 2014
[Phosphate additives in food a potential public health risk. High phosphate levels can lead to cardiovascular disease]Peter Stenvinkel, Gerd Faxén Irving, Sigrid Wegener, et al.
Journal of Plastic Surgery and Hand Surgery|January 12, 2018
Benefits and risks with acellular dermal matrix (ADM) and mesh support in immediate breast reconstruction: a systematic review and meta-analysisHåkan Hallberg, Svanheidur Rafnsdottir, Gennaro Selvaggi, et al.
Plos One|August 11, 2011
Oxidative stress and inflammation in renal patients and healthy subjectsDiana M Lee, Kenneth W Jackson, Nicholas Knowlton, et al.
Xenotransplantation|April 21, 2006
ABO-incompatible live donor renal transplantation using blood group A/B carbohydrate antigen immunoadsorption and anti-CD20 antibody treatmentGunnela Nordén, David Briggs, Paul Cockwell, et al.
Journal of Cardiac Failure|April 29, 2009
The influence of renal function on clinical outcome and response to beta-blockade in systolic heart failure: insights from Metoprolol CR/XL Randomized Intervention Trial in Chronic HF (MERIT-HF)Jalal K Ghali, John Wikstrand, Dirk J Van Veldhuisen, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 2, 2012
Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic-uraemic syndrome: an analysis of the German STEC-HUS registryJan T Kielstein, Gernot Beutel, Susanne Fleig, et al.
The New England Journal of Medicine|April 1, 2009
Rosuvastatin and cardiovascular events in patients undergoing hemodialysisBengt C Fellström, Alan G Jardine, Roland E Schmieder, et al.
BMJ (Clinical Research Ed.)|July 21, 2012
Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control studyJan Menne, Martin Nitschke, Robert Stingele, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Clinical Pharmacokinetics|July 9, 2003
Influence of severe renal impairment on the pharmacokinetics and pharmacodynamics of oral ximelagatran and subcutaneous melagatranUlf G Eriksson, Susanne Johansson, Per-Ola Attman, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 28, 2015
Measured and not estimated glomerular filtration rate should be used to assess renal function in heart transplant recipientsOscar Kolsrud, Sven-Erik Ricksten, Erik Holmberg, et al.
Lakartidningen|August 28, 2014
[Phosphate additives in food a potential public health risk. High phosphate levels can lead to cardiovascular disease]Peter Stenvinkel, Gerd Faxén Irving, Sigrid Wegener, et al.
Journal of Plastic Surgery and Hand Surgery|January 12, 2018
Benefits and risks with acellular dermal matrix (ADM) and mesh support in immediate breast reconstruction: a systematic review and meta-analysisHåkan Hallberg, Svanheidur Rafnsdottir, Gennaro Selvaggi, et al.
Plos One|August 11, 2011
Oxidative stress and inflammation in renal patients and healthy subjectsDiana M Lee, Kenneth W Jackson, Nicholas Knowlton, et al.
Xenotransplantation|April 21, 2006
ABO-incompatible live donor renal transplantation using blood group A/B carbohydrate antigen immunoadsorption and anti-CD20 antibody treatmentGunnela Nordén, David Briggs, Paul Cockwell, et al.
Journal of Cardiac Failure|April 29, 2009
The influence of renal function on clinical outcome and response to beta-blockade in systolic heart failure: insights from Metoprolol CR/XL Randomized Intervention Trial in Chronic HF (MERIT-HF)Jalal K Ghali, John Wikstrand, Dirk J Van Veldhuisen, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 2, 2012
Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic-uraemic syndrome: an analysis of the German STEC-HUS registryJan T Kielstein, Gernot Beutel, Susanne Fleig, et al.
The New England Journal of Medicine|April 1, 2009
Rosuvastatin and cardiovascular events in patients undergoing hemodialysisBengt C Fellström, Alan G Jardine, Roland E Schmieder, et al.
BMJ (Clinical Research Ed.)|July 21, 2012
Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control studyJan Menne, Martin Nitschke, Robert Stingele, et al.
Pageof 5